SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Xylem Inc. (XYL) trades at a trailing P/E of 32.6, forward P/E of 23.6. Trailing earnings yield is 3.07%, forward earnings yield 4.24%. PEG 4.40. Graham Number is $65.35.
Criteria proven by this page:
- VALUE (32/100, Fail) — PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 4.40).
- Forward P/E 23.6 (down from trailing 32.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 4.40 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 3.07% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.24% as earnings recover.
- Analyst consensus target $162.67 (+25.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 69/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
32/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — XYL
Valuation Multiples
P/E (TTM)32.6
Forward P/E23.6
PEG Ratio4.40
Forward PEG0.59
P/B Ratio2.71
P/S Ratio3.45
EV/EBITDA17.7
Per Share Data
EPS (TTM)$3.93
Forward EPS (Est.)$5.50
Book Value / Share$48.27
Revenue / Share$37.12
FCF / Share$3.74
Yields & Fair Value
Earnings Yield3.07%
Forward Earnings Yield4.24%
Dividend Yield1.27%
Graham Number$65.35
SharesGrow IV$170.88 (+31.8%)
Analyst Target$162.67 (+25.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
34.1 |
-1.49 |
4.05 |
2.35 |
1.26% |
| 2017 |
37.0 |
1.38 |
4.89 |
2.60 |
1.06% |
| 2018 |
21.9 |
0.33 |
4.33 |
2.30 |
1.27% |
| 2019 |
35.4 |
-1.32 |
4.80 |
2.70 |
1.23% |
| 2020 |
72.2 |
-1.96 |
6.18 |
3.76 |
1.03% |
| 2021 |
50.6 |
0.74 |
6.72 |
4.16 |
0.94% |
| 2022 |
56.1 |
-3.33 |
5.70 |
3.61 |
1.09% |
| 2023 |
40.7 |
0.96 |
2.44 |
3.37 |
1.20% |
| 2024 |
31.6 |
1.03 |
2.64 |
3.29 |
1.24% |
| 2025 |
34.6 |
4.89 |
2.89 |
3.67 |
1.18% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.45 |
$3.77B |
$260M |
6.9% |
| 2017 |
$1.83 |
$4.71B |
$331M |
7% |
| 2018 |
$3.03 |
$5.21B |
$549M |
10.5% |
| 2019 |
$2.21 |
$5.25B |
$401M |
7.6% |
| 2020 |
$1.40 |
$4.88B |
$254M |
5.2% |
| 2021 |
$2.35 |
$5.2B |
$427M |
8.2% |
| 2022 |
$1.96 |
$5.52B |
$355M |
6.4% |
| 2023 |
$2.79 |
$7.36B |
$609M |
8.3% |
| 2024 |
$3.65 |
$8.56B |
$890M |
10.4% |
| 2025 |
$3.92 |
$9.04B |
$957M |
10.6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$5.50 |
$5.42 – $5.57 |
$9.2B |
$9.11B – $9.26B |
14 |
| 2027 |
$6.07 |
$5.88 – $6.19 |
$9.61B |
$9.31B – $10.12B |
14 |
| 2028 |
$6.73 |
$6.57 – $6.84 |
$10.1B |
$10.08B – $10.12B |
4 |
| 2029 |
$7.61 |
$7.43 – $7.82 |
$10.7B |
$10.51B – $10.93B |
2 |
